New hope for liver transplant patients with severe low platelets
NCT ID NCT07600905
First seen May 24, 2026 · Last updated May 24, 2026
Summary
This study looked at whether a pill called avatrombopag can safely help liver transplant patients whose platelets drop dangerously low after surgery. Researchers compared 67 patients who got the drug with 67 similar patients who received standard care. The drug group had a faster rise in platelet counts, suggesting it may reduce bleeding risk, but patients still need ongoing monitoring and are not cured.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE COMPLICATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, 200032, China
Conditions
Explore the condition pages connected to this study.